Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Busch

Showing results (111-120 of 150) with videos related to

Pageof 15
Sort By:
Scientific Reports|April 7, 2021
Distinct SARS-CoV-2 antibody reactivity patterns in coronavirus convalescent plasma revealed by a coronavirus antigen microarrayRafael Assis, Aarti Jain, Rie Nakajima, et al.
Journal of Medicinal Chemistry|July 6, 2021
Structure-Based Optimization and Discovery of M3258, a Specific Inhibitor of the Immunoproteasome Subunit LMP7 (β5i)Markus Klein, Michael Busch, Manja Friese-Hamim, et al.
Transfusion|November 15, 2011
Vasovagal reactions in whole blood donors at three REDS-II blood centers in BrazilThelma T Gonçalez, Ester C Sabino, Karen S Schlumpf, et al.
Molecular Cancer Therapeutics|May 28, 2021
M3258 Is a Selective Inhibitor of the Immunoproteasome Subunit LMP7 (β5i) Delivering Efficacy in Multiple Myeloma ModelsMichael P Sanderson, Manja Friese-Hamim, Gina Walter-Bausch, et al.
Bioorganic & Medicinal Chemistry Letters|February 8, 2016
Discovery of potent and selective CDK8 inhibitors from an HSP90 pharmacophoreKai Schiemann, Aurélie Mallinger, Dirk Wienke, et al.
The Journal of Infectious Diseases|August 22, 2013
Variants in HAVCR1 gene region contribute to hepatitis C persistence in African AmericansGenevieve Wojcik, Rachel Latanich, Tim Mosbruger, et al.
Nature Communications|May 4, 2022
Using sero-epidemiology to monitor disparities in vaccination and infection with SARS-CoV-2Isobel Routledge, Saki Takahashi, Adrienne Epstein, et al.
The American Journal of Cardiology|October 1, 2014
Incidence of cancer and mortality in patients from the Simvastatin and Ezetimibe in Aortic Stenosis (SEAS) trialAnders Green, Dena Rosen Ramey, Martha Emneus, et al.
Medrxiv : the Preprint Server for Health Sciences|October 13, 2021
Using sero-epidemiology to monitor disparities in vaccination and infection with SARS-CoV-2Isobel Routledge, Saki Takahashi, Adrienne Epstein, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 3, 2020
Affinity Maturation of B7-H6 Translates into Enhanced NK Cell-Mediated Tumor Cell Lysis and Improved Proinflammatory Cytokine Release of Bispecific Immunoligands via NKp30 EngagementLukas Pekar, Katja Klausz, Michael Busch, et al.
Pageof 15

Showing results (111-120 of 150) with videos related to

Sort By:
Pageof 15
Scientific Reports|April 7, 2021
Distinct SARS-CoV-2 antibody reactivity patterns in coronavirus convalescent plasma revealed by a coronavirus antigen microarrayRafael Assis, Aarti Jain, Rie Nakajima, et al.
Journal of Medicinal Chemistry|July 6, 2021
Structure-Based Optimization and Discovery of M3258, a Specific Inhibitor of the Immunoproteasome Subunit LMP7 (β5i)Markus Klein, Michael Busch, Manja Friese-Hamim, et al.
Transfusion|November 15, 2011
Vasovagal reactions in whole blood donors at three REDS-II blood centers in BrazilThelma T Gonçalez, Ester C Sabino, Karen S Schlumpf, et al.
Molecular Cancer Therapeutics|May 28, 2021
M3258 Is a Selective Inhibitor of the Immunoproteasome Subunit LMP7 (β5i) Delivering Efficacy in Multiple Myeloma ModelsMichael P Sanderson, Manja Friese-Hamim, Gina Walter-Bausch, et al.
Bioorganic & Medicinal Chemistry Letters|February 8, 2016
Discovery of potent and selective CDK8 inhibitors from an HSP90 pharmacophoreKai Schiemann, Aurélie Mallinger, Dirk Wienke, et al.
The Journal of Infectious Diseases|August 22, 2013
Variants in HAVCR1 gene region contribute to hepatitis C persistence in African AmericansGenevieve Wojcik, Rachel Latanich, Tim Mosbruger, et al.
Nature Communications|May 4, 2022
Using sero-epidemiology to monitor disparities in vaccination and infection with SARS-CoV-2Isobel Routledge, Saki Takahashi, Adrienne Epstein, et al.
The American Journal of Cardiology|October 1, 2014
Incidence of cancer and mortality in patients from the Simvastatin and Ezetimibe in Aortic Stenosis (SEAS) trialAnders Green, Dena Rosen Ramey, Martha Emneus, et al.
Medrxiv : the Preprint Server for Health Sciences|October 13, 2021
Using sero-epidemiology to monitor disparities in vaccination and infection with SARS-CoV-2Isobel Routledge, Saki Takahashi, Adrienne Epstein, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 3, 2020
Affinity Maturation of B7-H6 Translates into Enhanced NK Cell-Mediated Tumor Cell Lysis and Improved Proinflammatory Cytokine Release of Bispecific Immunoligands via NKp30 EngagementLukas Pekar, Katja Klausz, Michael Busch, et al.
Pageof 15